Atlanta, GA - Southeast BIO (SEBIO) announced that it has selected ten semifinalists in its fourth annual BIO/Plan Competition. Launched in 2007, the BIO/Plan Competition is a program developed to promote the creation of new life science companies based in the Southeast. (more…)

Franklin, TN - BioMimetic Therapeutics, Inc. (NASDAQ: BMTI), announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share. After underwriting discounts and commissions and estimated offering expenses, BioMimetic received net proceeds of approximately $45 million. (more…)

WINSTON SALEM, NC  – New research accepted by the Journal of Molecular Recognition confirms that a revolutionary technology developed at Wake Forest University will slash years off the time it takes to develop drugs – bringing vital new treatments to patients much more quickly. (more…)

ATLANTA – InVasc Therapeutics, Inc., a clinical stage biopharmaceutical company developing drugs to treat or prevent cardiometabolic disease, plans to raise $12 million, according to a regulatory filing. (more…)

Atlanta, GA – InVasc Therapeutics, Inc., a clinical stage biopharmaceutical company developing drugs to treat or prevent cardiometabolic disease has closed on $3,150,000 in its first institutional financing from Trois Investments Industriels Internationaux of Luxembourg. (more…)

Washington, DC - Today the IRS released Form 8942, the application to receive a tax credit or grant for qualifying therapeutic discovery projects. (more…)

High Point, NC – TransTech Pharma will receive a $50 million up front payment from Forest Laboratories in a collaboration deal that could be worth more than $1.1 billion in potential fees. (more…)

Boca Raton, FL – Watermark Medical Inc., a medical products and services company currently servicing the sleep-disordered breathing market, has closed a $15 million equity round from CA Technologies (Nasdaq:CA). (more…)

Research Triangle Park, NC – Barcelona-based Grifols, the largest maker of blood plasma products in Europe, has agreed to pay $3.4 billion for Talecris Biotherapeutics Holdings Corp. (more…)

Palm Beach Gardens, FL – Accudial Pharmaceutical Inc. has closed on more than half of a $7 million offering, according to a regulatory filing. The company, which sells a dosing system for administering over-the-counter children’s medication, has secured $4.6 million of the raise, according to a filing with the U.S. Securities and Exchange Commission. (more…)